Literature DB >> 3155633

Adrenergic and serotoninergic mechanisms in human hand arteries and veins studied by fluorescence histochemistry and in vitro pharmacology.

B Arneklo-Nobin, C Owman.   

Abstract

Isolated hand arteries and veins from healthy human subjects were tested in vitro for their contractile response to adrenergic agonists and 5-hydroxytryptamine (5-HT) under standardized conditions. This allowed for quantitative estimation of various receptor characteristics. The relative sympathomimetic potency suggested alpha-adrenergic receptors, which was confirmed in Schild plots following phentolamine antagonism of the response (pA2 for artery 7.57, for vein 7.75). 5-HT contracted with a relative potency approximately equal to noradrenaline and adrenaline in arteries, but only one fifth to one tenth of the catecholamine activity in veins. Ketanserin inhibited the 5-HT response in a competitive, probably also irreversible, manner in arteries (pA2 9.50, KA 8.90 X 10(-7) M). In the veins, ketanserin counteracted the 5-HT-induced contraction in a noncompetitive way.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3155633

Source DB:  PubMed          Journal:  Blood Vessels        ISSN: 0303-6847


  3 in total

1.  Digital blood flow and 5-hydroxytryptamine receptor blockade after ketanserin in patients with Raynaud's phenomenon.

Authors:  B Marasini; C Bassani
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

2.  Heterogeneity of 5-HT receptor subtypes in isolated human femoral and saphenous veins.

Authors:  E Glusa; E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

3.  Histamine and H1 -histamine receptors faster venous circulation.

Authors:  Zoltan Galajda; Jozsef Balla; A Jozsef Szentmiklosi; Tamas Biro; Gabriella Czifra; Nora Dobrosi; Agnes Cseppento; Lajos Patonay; Tamas Roszer; Gyorgy Balla; Laurenciu M Popescu; Istvan Lekli; Arpad Tosaki
Journal:  J Cell Mol Med       Date:  2011-12       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.